Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

N/T RHEUMATOLOGY CONTROL SL/1 AND SL/2

K-Number: K962373 · 1996-07-11

ApplicantBehring Diagnostics, Inc.
Decision Date1996-07-11
Product CodeDCK
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

N/T RHEUMATOLOGY CONTROL SL/1 AND SL/2 is the device name listed in this FDA 510(k) record. The listed applicant is Behring Diagnostics, Inc.. It received FDA 510(k) clearance on 1996-07-11 under 510(k) number K962373. The device is classified under product code DCK. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the N/T RHEUMATOLOGY CONTROL SL/1 AND SL/2?

N/T RHEUMATOLOGY CONTROL SL/1 AND SL/2 is a medical device that received FDA 510(k) clearance on 1996-07-11. The listed applicant is Behring Diagnostics, Inc.. The 510(k) number is K962373.

When did N/T RHEUMATOLOGY CONTROL SL/1 AND SL/2 receive FDA 510(k) clearance?

N/T RHEUMATOLOGY CONTROL SL/1 AND SL/2 received FDA 510(k) clearance on 1996-07-11, under 510(k) number K962373.

Who is the listed applicant for N/T RHEUMATOLOGY CONTROL SL/1 AND SL/2?

The FDA 510(k) record lists Behring Diagnostics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for N/T RHEUMATOLOGY CONTROL SL/1 AND SL/2?

The FDA product code for N/T RHEUMATOLOGY CONTROL SL/1 AND SL/2 is DCK.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Behring Diagnostics, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K973832OPUS HLH CONTROLSK972929N ANTISERUM TO HUMAN ALBUMINK972840N ANTISERUM TO HUMAN TRANSFERRINK973202MODIFICATION OF OPUS FERRITIN TEST SYSTEMK972316OPUS D-DIMERK972116VON WILLEBRAND REAGENT

View all 145 devices →

Related Devices (Code: DCK)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K242170K-ASSAY CRP (Ver.2)Kamiya Biomedical Company, LLCK201256Procise CRP, ProciseDx Analyzer, ProciseDx Calibration CartridgeProcise DiagnosticsK192028Yumizen C1200 CRPHORIBA ABX SASK192118CRP VarioSENTINEL CH. SpAK191993Yumizen C1200 CRPHORIBA ABX SASK160712VITROS Chemistry Products hsCRP ReagentOrtho Clinical Diagnostics

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑